Health-IT Helps Deal with Wildfire Displaced Patients' Needs

Author: Adam Stone

In the wake of this month's wildfires, residents of Southern California may not be sleeping in their beds, but at least they should have access to their meds. Once the president declared a state of emergency in the area, a public/private initiative known as ICERx.org went into action. Established in 2005 in the wake of Hurricane Katrina, the prescription history service makes available vital medical records to personnel in an emergency zone.

The system has a lot of moving parts, bringing together a wide range of groups who may have access to patients' pharmaceutical histories. Partners include the American Medical Association (AMA), Informed Decisions, the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA), RxHub, and SureScripts. The organization has no budget, as all partners donate their services pro bono.

It works like this. When emergency workers need access to patients' drug histories, they call the AMA on a toll-free line. The AMA validates their credentials and grants them passwords giving access to the ICERx (In Case of Emergency Prescription) web portal.

"A critical piece in the delivery of ICERx.org is a concise user interface that allows the prescriber to quickly find the information he or she needs, when treating patients in an unpredictable and potentially unstable environment," said Kathy Mosbaugh, executive vice president of Informed Decisions.

Through the portal the practitioner can find a listing of prescription medications taken by the evacuee including quantity and day supply, the pharmacy that filled the prescription, and the provider who wrote the prescription.

"We try to make it very simple for the people who need the information to get to the information," Mosbaugh said.

Through prescription management services like RxHub and SureScripts, the system is able to pull data from community pharmacies, pharmacy benefit managers, and state Medicaid programs. Mosbaugh estimates that these services together can provide drug histories on 70- to 75 percent of all Americans.

Participants connect to the system via a proprietary ASCII-based messaging tool. This connectivity arrangement incorporates standardization tools crafted by the National Council for Prescription Drug Programs, Inc. (NCPDP) and by Health Level Seven, one of several American National Standards Institute (ANSI) -accredited standards developing organizations operating in the health care realm.

All this falls within the context of a HIPAA-defined Standard Transaction Format.

Even with the pipe in place to connect all players to the system, Mosbaugh says it still took a lot of planning to connect the dots. When doctors call the hotline, for instance, the AMA has to have ready access to the ICERx system in order to deliver valid pass codes.

The California fires will be an important test of the system, as this is its first full-scale implementation since being organized in the wake of Katrina. If all goes as planned, medical personnel will have access not just to patient histories but also to clinical-decision support tools including drug identifiers and drug interaction data.

This information is a key piece of the puzzle in an emergency, Mosbaugh said With thousands of evacuees in need of help, "you need whoever can give their time to help you, and they may not all be familiar with all the medications," she said. When pediatricians are caring for the elderly, for example, "they may not be used to prescribing the medication you are taking."

All of this centers upon the partners' open exchange of confidential, personal medical information. This ought to ring HIPAA bells, but organizers say the system is in the clear.

A 2002 HHS revision to HIPAA gave providers, payers, and claims clearinghouses the right to exchange patients' protected health care information without the patient's consent when the information is needed for treatment. Mosbaugh said ICERx is covered. "This information is only being accessed in the instance of providing care, and for no other reason, and only in time of emergency," she said.

Want to read more expert articles like this? Click here to subscribe to Digital HealthCare & Productivity.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Waters

NuGenesis SDMS: Improving Data Accessibility and Intellectual Property Management

Global pharmaceutical company improves the accessibility and intellectual property managment of drung candidate data with Waters® NuGenesis® SDMS software.



Life Science Webcasts & Podcasts

Waters

Streamlining the Chromatographic Method Validation Process

Waters® Empower™ 2 Method Validation Manager (MVM) is a business-critical, compliant-ready software that reduces time and costs required to perform chromatographic method validation by as much as 80%. Learn in this podcast how MVM streamlines the method validation process and allows the entire process to be efficiently performed within Empower 2, so fewer software applications need be deployed, validated, and maintained. Download Now


More Podcasts

Job Openings

GNS Biotech - Computational Scientist, Biological Applications
Candidates must have a combination of experience in the following areas: bioinformatics, microarray data analysis, algorithm development, statistics, machine learning, and network inference or reverse engineering methods. Successful candidates will have a PhD (or be equivalently qualified) in Physics, Applied Mathematics, Computational Biology, Operations Research, or Engineering or have similar training thereof in the computational and biological sciences and 3+ years experience in the field. Must work fluidly with a fast moving, interdisciplinary team, have excellent communication skills and a passion for learning new science. For more information please visit http://www.gnsbiotech.com/careers/openings/

GNS Biotech - Computational Scientist, Discovery Biology
The successful candidate will reverse engineer models from large coherent data sets. In addition, the candidate will complete genome-wide association analysis of disease and drug-response and develop methods to deal with population genetic structure, pedigrees, missing data and computational scaling. The candidate will be comfortable handing millions of marker and molecular phenotype data points using database management systems and statistical scripting, and will show familiarity with data issues regarding major genotyping platforms and external database resources. Must work fluidly with a fast moving, interdisciplinary team, have excellent communication skills and a passion for learning new science. For more information please visit
http://www.gnsbiotech.com/careers/openings/

Sponsored Links

Related Resources & Products

Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
Patient Recruitment and Retention 2008
The Need for a New Molecular Diagnostic Business Model to Fit the Needs of Personalized Medicine



For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext 100 or via email to [email protected].